Pinaverium

Delibs F.C. Tablets 50MG

膜衣錠TaiwanAuthorisedAuthorised 1 May 2001

In other countries

The same active substances on other registers, the same brand first.

DicetelCanada · 50 MG · Tablet · BGP Pharma UlcSame substance
DicetelCanada · 100 MG · Tablet · BGP Pharma UlcSame substance
PinaveriumCanada · 100 MG · Tablet · Aa Pharma INCSame substance
ELDICET 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULASpain · 50 mg · comprimido recubierto con película · Viatris Healthcare LimitedSame substance
Dicetel 100 mg filmom obložene tableteCroatia · filmom obložena tableta · Viatris Hrvatska d.o.o., Koranska 2, Zagreb, HrvatskaSame substance
DicetelItaly · Compressa rivestita · Viatris Italia S.R.L.Same substance
Dicetel Tab 50MGSaudi Arabia · Abbott Healthcare SasSame substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Pinaverium

Delibs F.C. Tablets 50MG

膜衣錠TaiwanAuthorisedAuthorised 1 May 2001

Ask Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Taiwan Food and Drug Administration

TFDA, dataset 9122, Government Open Data Licence 1.0; source update and retrieval dates

Licence: Taiwan Government Open Data Licence 1.0 · Added 7 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Pinaverium
Dosage form: 膜衣錠
Register: Taiwan (TFDA)
Status: Authorised
Authorised: 1 May 2001
Registration: 衛署藥製字第044434號
Marketing authorisation holder: 加拿安股份有限公司
Procedure: 製　劑